Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atrasentan Spermatogenesis Study
NCT02118714Phase 2Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2015
- Primary completion
- Apr 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of atrasentan in diabetic nephropathy (DN), sponsored by AbbVie Inc.. Started Apr 2015; status: completed.
02
Drugs
atrasentan
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT02118714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02118714.